Edesa Biotech, Inc. ( EDSA) - Key Metrics
EDSA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | -$0.60 | -$0.34 | -$0.34 |
| 2026Q2 | $0 | -$0.51 | -$0.25 | -$0.25 |
| 2026Q1 | $0 | -$0.28 | -$0.26 | -$0.26 |
| 2025Q4 | $0 | -$0.32 | -$0.25 | -$0.25 |
| 2025Q3 | $0 | -$0.25 | -$0.25 | -$0.25 |
EDSA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -3.39 |
| 2026Q2 | 0% | -2.67 |
| 2026Q1 | 0% | -1.27 |
| 2025Q4 | 0% | -1.93 |
| 2025Q3 | 0% | -2.03 |
EDSA
Price: $3.91
52 week price:
Earnings Per Share: -1.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 79700
Market Capitalization: 45.6 million